Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 22 min ago
Peer-reviewedCC BYCancers

Adjuvant and Perioperative Systemic Therapy for Resectable Hepatocellular Carcinoma: Evidence, Biological Rationale, and Trial Design

  • Xin Xin1
  • Ruoyu Miao2
  1. 1BayCare Health Systems, St. Joseph’s Hospital, Tampa, FL 33607, USA;
  2. 2Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA 30322, USA
Read full textPDFCite

Related

  1. The Rationale for Tissue Biopsy in the Era of Precision Hepatocellular Carcinoma Management
    Ioanna-Maria Grypari, Dina G. Tiniakos, Maria Kalafateli +1
    CancersPeer-reviewedCC BYFull textOncologyEurope PMC
  2. DUBHE-H-308 study protocol: rationale and adaptive design of a randomized, open-label, seamless phaseII/III trial of iparomlimab and tuvonralimab (QL1706)-based regimens versus sintilimab plus bevacizumab as first-line treatment for advanced hepatocellular carcinoma
    Fan Yang, Weikang Tao, Zihang Zhong +3
    Future OncologyPeer-reviewedLicence not statedFull textGeneral medicinePMC
  3. Foundation Model-Enabled Pathology-Informed MRI Model for Preoperative Prediction of Vessels Encapsulating Tumor Clusters in Resectable Hepatocellular Carcinoma: A Multicenter Retrospective Study.
    Zhehan Shen, Wanmin Liu, Xiaoming Li +10
    Advanced science (Weinheim, Baden-Wurttemberg, Germany)Peer-reviewedCC BYFull textMedical imaging & radiologyEurope PMC
  4. Prognosis and Safety of Neoadjuvant Therapy Plus Surgery versus Upfront Surgery in Patients with Resectable Hepatocellular Carcinoma at CNLC Ib-IIa Stage: A Propensity Score Matching Study.
    Bohan Xiang, Lei Xu, Jieshen Shan +7
    Journal of hepatocellular carcinomaPeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
  5. A cohort study on efficacy and safety of treatment modalities for resectable hepatocellular carcinoma with extrahepatic metastasis
    Tai-xin Yang, Zhan Lu, Jie Zhang +8
    ILIVERPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMCEurope PMCPMC

Cite

BibTeXRIS
BibTeX
@article{xin2026adjuvant,
  title = {{Adjuvant and Perioperative Systemic Therapy for Resectable Hepatocellular Carcinoma: Evidence, Biological Rationale, and Trial Design}},
  author = {Xin Xin and Ruoyu Miao},
  journal = {Cancers},
  year = {2026},
  month = sep,
  url = {https://europepmc.org/article/PMC/PMC13663957},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Adjuvant and Perioperative Systemic Therapy for Resectable Hepatocellular Carcinoma: Evidence, Biological Rationale, and Trial Design
AU  - Xin Xin
AU  - Ruoyu Miao
PY  - 2026
DA  - 2026/09/27
JO  - Cancers
UR  - https://europepmc.org/article/PMC/PMC13663957
SN  - 2072-6694
ER  -